Intellectual Property News & Topics - Secerna LLP

A To Z Drugs In Highlight T Is For TECFIDERA®

A to Z: Drugs in Highlight: T is for TECFIDERA®

News A to Z Feature 17/04/2025

This series continues to explore the fascinating world of pharmaceuticals. Next up is T is for TECFIDERA. TECFIDERA (from Biogen) is a disease modifying therapy used for treating people with relapsing-remitting Multiple Sclerosis (MS).

Read more

A To Z Drugs In Highlight T Is For TECFIDERA®

News, A to Z Feature 17/04/2025

A to Z: Drugs in Highlight: T is for TECFIDERA®

AI Image Secerna LLP

European, News 16/04/2025

Updated European Patent Convention Guidelines for AI Inventions

Use It Or Lose It A Reminder To The Holders Of Comparable Registrations Main

European, News 15/04/2025

Use it or Lose it: A reminder to the holders of Comparable Registrations

STRIBILD

News, A to Z Feature 10/04/2025

A to Z: Drugs in Highlight: S is for STRIBILD®

Seas The Day Start

Events, News 08/04/2025

Seas The Day: Pacific Row Begins - Follow Their Epic Journey

JBOAKES - Secerna

Events, News, Team news 07/04/2025

Jason Boakes will be in San Diego (17th - 22nd May)

REXULTI

News, A to Z Feature 03/04/2025

A to Z: Drugs in Highlight: R is for REXULTI®

LAOS EPO

European, News 03/04/2025

European Patent Validation in Laos

YNYCA (1)

Events, News, Team news 01/04/2025

Webinar: Why does Intellectual Property matter to your business?

1 2 3 4 5 6